Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


27.11.2017

1 Acta Ophthalmol
2 Am J Kidney Dis
1 BMJ
1 Circ Cardiovasc Interv
1 Diabet Med
4 Diabetes
10 Diabetes Care
8 Diabetes Obes Metab
4 Diabetologia
1 Invest Ophthalmol Vis Sci
1 J Clin Endocrinol Metab
3 J Diabetes Complications
1 J Immunol
1 JAMA
1 N Engl J Med
1 Ophthalmology
3 Pediatr Diabetes
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. CHEN C, Chen X, Huang H, Han C, et al
    Elevated plasma and vitreous levels of leucine-rich-alpha2-glycoprotein are associated with diabetic retinopathy progression.
    Acta Ophthalmol. 2017 Nov 23. doi: 10.1111/aos.13633.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  2. BJORNSTAD P, Nehus E, El Ghormli L, Bacha F, et al
    Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Am J Kidney Dis. 2017 Nov 17. pii: S0272-6386(17)30893.
    PubMed     Text format     Abstract available

  3. WELDEGIORGIS M, de Zeeuw D, Li L, Parving HH, et al
    Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.
    Am J Kidney Dis. 2017 Nov 16. pii: S0272-6386(17)30906.
    PubMed     Text format     Abstract available


    BMJ

  4. HIPPISLEY-COX J, Coupland C
    Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    BMJ. 2017;359:j5019.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  5. DIAB OA, Helmy M, Gomaa Y, El-Shalakany R, et al
    Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.
    Circ Cardiovasc Interv. 2017;10:e004348.
    PubMed     Text format     Abstract available


    Diabet Med

  6. JEFFCOATE W, Young B
    Reducing amputation in diabetes: work from the West Country provides both evidence and a tool-kit.
    Diabet Med. 2017 Nov 22. doi: 10.1111/dme.13538.
    PubMed     Text format    


    Diabetes

  7. CHENG Y, Du Y, Liu H, Tang J, et al
    Photobiodulation Inhibits Long-Term Structural and Functional Lesions of Diabetic Retinopathy.
    Diabetes. 2017 Nov 22. pii: db170803. doi: 10.2337/db17-0803.
    PubMed     Text format     Abstract available

  8. KNIGHT CM, Gutierrez-Juarez R, Lam TKT, Arrieta-Cruz I, et al
    Erratum. Mediobasal Hypothalamic SIRT1 Is Essential for Resveratrol's Effects on Insulin Action in Rats. Diabetes 2011;60:2691-2700.
    Diabetes. 2017;66:3143-3144.
    PubMed     Text format    

  9. MANDRUP-POULSEN T
    Granzyme A in the Pathogenesis of Type 1 Diabetes: The Yes and the No.
    Diabetes. 2017;66:2937-2939.
    PubMed     Text format    


  10. In This Issue of Diabetes.
    Diabetes. 2017;66:2935-2936.
    PubMed     Text format    


    Diabetes Care


  11. In This Issue of Diabetes Care.
    Diabetes Care. 2017;40:1609-1610.
    PubMed     Text format    

  12. AGIOSTRATIDOU G, Anhalt H, Ball D, Blonde L, et al
    Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the
    Diabetes Care. 2017;40:1622-1630.
    PubMed     Text format     Abstract available

  13. CRYER PE
    Individualized Glycemic Goals and an Expanded Classification of Severe Hypoglycemia in Diabetes.
    Diabetes Care. 2017;40:1641-1643.
    PubMed     Text format     Abstract available

  14. CRADOCK KA, OLaighin G, Finucane FM, McKay R, et al
    Diet Behavior Change Techniques in Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2017;40:1800-1810.
    PubMed     Text format     Abstract available

  15. PINTAUDI B, Di Vieste G
    Comment on Farren et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care 2017;40:759-763.
    Diabetes Care. 2017;40:e172.
    PubMed     Text format    

  16. FELDMAN-BILLARD S
    Comment on Kaul. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821-831.
    Diabetes Care. 2017;40:e174.
    PubMed     Text format    

  17. FARREN M, Turner MJ, Daly S
    Response to Comment on Farren et al. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care 2017;40:759-763.
    Diabetes Care. 2017;40:e173.
    PubMed     Text format    

  18. MEIDTNER K, Podmore C, Kroger J, van der Schouw YT, et al
    Interaction of Dietary and Genetic Factors Influencing Body Iron Status and Risk of Type 2 Diabetes Within the EPIC-InterAct Study.
    Diabetes Care. 2017 Nov 22. pii: dc171080. doi: 10.2337/dc17-1080.
    PubMed     Text format     Abstract available

  19. WILD SH, Walker JJ, Morling JR, McAllister DA, et al
    Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
    Diabetes Care. 2017 Nov 22. pii: dc171590. doi: 10.2337/dc17-1590.
    PubMed     Text format     Abstract available

  20. KAUL S
    Response to Comment on Kaul. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821-831.
    Diabetes Care. 2017;40:e175-e176.
    PubMed     Text format    


    Diabetes Obes Metab

  21. BETTGE K, Kahle M, Abd El Aziz MS, Meier JJ, et al
    Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials.
    Diabetes Obes Metab. 2017;19:336-347.
    PubMed     Text format     Abstract available

  22. BAIN S, Druyts E, Balijepalli C, Baxter CA, et al
    Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.
    Diabetes Obes Metab. 2017;19:329-335.
    PubMed     Text format     Abstract available

  23. CAMASTRA S, Astiarraga B, Tura A, Frascerra S, et al
    Effect of exenatide on postprandial glucose fluxes, lipolysis, and ss-cell function in non-diabetic, morbidly obese patients.
    Diabetes Obes Metab. 2017;19:412-420.
    PubMed     Text format     Abstract available

  24. KOZLOVSKI P, Fonseca M, Mohan V, Lukashevich V, et al
    Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies.
    Diabetes Obes Metab. 2017;19:429-435.
    PubMed     Text format     Abstract available

  25. DRIESSEN JH, van den Bergh JP, van Onzenoort HA, Henry RM, et al
    Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
    Diabetes Obes Metab. 2017;19:421-428.
    PubMed     Text format     Abstract available

  26. NEAL B, Perkovic V, Matthews DR, Mahaffey KW, et al
    Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal (CANVAS-R): A randomized, placebo-controlled trial.
    Diabetes Obes Metab. 2017;19:387-393.
    PubMed     Text format     Abstract available

  27. KNAPEN LM, de Jong RG, Driessen JH, Keulemans YC, et al
    Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
    Diabetes Obes Metab. 2017;19:401-411.
    PubMed     Text format     Abstract available

  28. YE M, Robson PJ, Eurich DT, Vena JE, et al
    Systemic Use of Antibiotics and Risk of Diabetes in Adults: A Nested Case-control Study of Alberta's Tomorrow Project.
    Diabetes Obes Metab. 2017 Nov 20. doi: 10.1111/dom.13163.
    PubMed     Text format     Abstract available


    Diabetologia

  29. HUANG Y, Chen X, Chen X, Feng Y, et al
    Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes.
    Diabetologia. 2017 Nov 22. doi: 10.1007/s00125-017-4505.
    PubMed     Text format     Abstract available

  30. WALASZCZYK E, Luijten M, Spijkerman AMW, Bonder MJ, et al
    DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case-control sample of the Lifelines study.
    Diabetologia. 2017 Nov 21. doi: 10.1007/s00125-017-4497.
    PubMed     Text format     Abstract available

  31. STONE VM, Hankaniemi MM, Svedin E, Sioofy-Khojine A, et al
    A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
    Diabetologia. 2017 Nov 18. doi: 10.1007/s00125-017-4492.
    PubMed     Text format     Abstract available

  32. KONING SH, van Zanden JJ, Hoogenberg K, Lutgers HL, et al
    New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes.
    Diabetologia. 2017 Nov 22. doi: 10.1007/s00125-017-4506.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  33. SRINIVASAN S, Raman R, Swaminathan G, Ganesan S, et al
    Incidence, Progression, and Risk Factors for Cataract in Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:5921-5929.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  34. LI K, Liao X, Wang K, Mi Q, et al
    Myonectin Predicts the Development of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2017 Nov 16. doi: 10.1210/jc.2017-01604.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  35. TANENBAUM ML, Adams RN, Gonzalez JS, Hanes SJ, et al
    Adapting and validating a measure of diabetes-specific self-compassion.
    J Diabetes Complications. 2017 Oct 26. pii: S1056-8727(17)31350.
    PubMed     Text format     Abstract available

  36. NGUYEN E, Coleman CI, Nair S, Weeda ER, et al
    Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk.
    J Diabetes Complications. 2017 Oct 14. pii: S1056-8727(17)31259.
    PubMed     Text format     Abstract available

  37. TEIGLAND T, Iversen MM, Sangnes DA, Dimcevski G, et al
    A longitudinal study on patients with diabetes and symptoms of gastroparesis - associations with impaired quality of life and increased depressive and anxiety symptoms.
    J Diabetes Complications. 2017 Nov 16. pii: S1056-8727(16)30961.
    PubMed     Text format     Abstract available


    J Immunol

  38. BURG AR, Das S, Padgett LE, Koenig ZE, et al
    Superoxide Production by NADPH Oxidase Intensifies Macrophage Antiviral Responses during Diabetogenic Coxsackievirus Infection.
    J Immunol. 2017 Nov 20. pii: ji1700478. doi: 10.4049/jimmunol.1700478.
    PubMed     Text format     Abstract available


    JAMA

  39. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Text format     Abstract available


    N Engl J Med


  40. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017;377:2097-2099.
    PubMed     Text format    


    Ophthalmology

  41. THOMAS M, Rao RC, Johnson MW, Paulus YM, et al
    Re: Bressler et al.: Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab (Ophthalmology. 2017;124:431-439).
    Ophthalmology. 2017;124:e87-e88.
    PubMed     Text format    


    Pediatr Diabetes

  42. THOMAS I, Gregg B
    Metformin; a review of its history and future: from lilac to longevity.
    Pediatr Diabetes. 2017;18:10-16.
    PubMed     Text format     Abstract available

  43. SKINNER TC, Lange KS, Hoey H, Mortensen HB, et al
    Targets and teamwork: Understanding differences in pediatric diabetes centers treatment outcomes.
    Pediatr Diabetes. 2017 Nov 20. doi: 10.1111/pedi.12606.
    PubMed     Text format     Abstract available

  44. HOEY H, Lange K, Skinner TC, Mortensen H, et al
    Hvidoere Smiley Faces: International diabetes quality of life assessment tool for young children.
    Pediatr Diabetes. 2017 Nov 22. doi: 10.1111/pedi.12602.
    PubMed     Text format     Abstract available


    PLoS One

  45. WU Y, Yu J, Jin C, Li Y, et al
    Longitudinal fasting blood glucose patterns and arterial stiffness risk in a population without diabetes.
    PLoS One. 2017;12:e0188423.
    PubMed     Text format     Abstract available

  46. AL-RIFAI RH, Pearson F, Critchley JA, Abu-Raddad LJ, et al
    Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0187967.
    PubMed     Text format     Abstract available

  47. GIBBONS SJ, Grover M, Choi KM, Wadhwa A, et al
    Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis.
    PLoS One. 2017;12:e0187772.
    PubMed     Text format     Abstract available

  48. MIYAZAWA M, Takatori H, Shimakami T, Kawaguchi K, et al
    Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    PLoS One. 2017;12:e0188549.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: